For help on how to get the results you want, see our search tips.
3819 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Direct healthcare professional communication Remove Direct healthcare professional communication filter
Withdrawn applications Remove Withdrawn applications filter
Periodic safety update report single assessments Remove Periodic safety update report single assessments filter
-
List item
Veterinary medicine European public assessment report (EPAR): Spironolactone Ceva (updated)
spironolactone, Dogs
Date of authorisation: 20/06/2007, Revision: 7, Authorised, Last updated: 24/02/2021 -
List item
Human medicine European public assessment report (EPAR): Ziagen (updated)
abacavir, HIV Infections
Date of authorisation: 08/07/1999, Revision: 42, Authorised, Last updated: 24/02/2021 -
List item
Human medicine European public assessment report (EPAR): Pregabalin Accord (updated)
pregabalin, Anxiety Disorders, Epilepsy
Date of authorisation: 28/08/2015,
, Revision: 9, Authorised, Last updated: 24/02/2021
-
List item
Human medicine European public assessment report (EPAR): Levetiracetam Sun (updated)
levetiracetam, Epilepsy
Date of authorisation: 14/12/2011,, Revision: 14, Authorised, Last updated: 24/02/2021
-
List item
Human medicine European public assessment report (EPAR): Inhixa (updated)
enoxaparin sodium, Venous Thromboembolism
Date of authorisation: 15/09/2016,
, 
, Revision: 17, Authorised, Last updated: 24/02/2021
-
List item
Veterinary medicine European public assessment report (EPAR): Easotic (updated)
gentamicin sulphate, hydrocortisone aceponate, miconazole nitrate, Dogs
Date of authorisation: 19/11/2008, Revision: 9, Authorised, Last updated: 24/02/2021 -
List item
Human medicine European public assessment report (EPAR): Ristfor (updated)
sitagliptin, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 15/03/2010, Revision: 23, Authorised, Last updated: 24/02/2021 -
List item
Human medicine European public assessment report (EPAR): Xtandi (updated)
enzalutamide, Prostatic Neoplasms
Date of authorisation: 21/06/2013,
Date of refusal: 26/04/2013, Revision: 16, Authorised, Last updated: 24/02/2021 -
List item
Human medicine European public assessment report (EPAR): Efficib (updated)
sitagliptin, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 15/07/2008, Revision: 28, Authorised, Last updated: 24/02/2021 -
List item
Human medicine European public assessment report (EPAR): Neparvis (updated)
sacubitril, valsartan, Heart Failure
Date of authorisation: 26/05/2016,, Revision: 11, Authorised, Last updated: 24/02/2021
-
List item
Human medicine European public assessment report (EPAR): Descovy (updated)
emtricitabine, tenofovir alafenamide, HIV Infections
Date of authorisation: 21/04/2016, Revision: 17, Authorised, Last updated: 24/02/2021 -
List item
Human medicine European public assessment report (EPAR): Cinryze (updated)
C1 inhibitor (human), Angioedemas, Hereditary
Date of authorisation: 15/06/2011,, Revision: 19, Authorised, Last updated: 24/02/2021
-
List item
Human medicine European public assessment report (EPAR): Rolufta Ellipta (previously Rolufta) (updated)
umeclidinium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 20/03/2017,, Revision: 9, Authorised, Last updated: 24/02/2021
-
List item
Human medicine European public assessment report (EPAR): Tobi Podhaler (updated)
Tobramycin, Cystic Fibrosis, Respiratory Tract Infections
Date of authorisation: 20/07/2011,
, Revision: 17, Authorised, Last updated: 24/02/2021
-
List item
Human medicine European public assessment report (EPAR): Conbriza (updated)
bazedoxifene, Osteoporosis, Postmenopausal
Date of authorisation: 17/04/2009, Revision: 14, Authorised, Last updated: 24/02/2021 -
List item
Human medicine European public assessment report (EPAR): Xelevia (updated)
sitagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 21/03/2007, Revision: 31, Authorised, Last updated: 24/02/2021 -
List item
Human medicine European public assessment report (EPAR): Latuda (updated)
lurasidone, Schizophrenia
Date of authorisation: 21/03/2014, Revision: 21, Authorised, Last updated: 24/02/2021 -
List item
Human medicine European public assessment report (EPAR): Neoclarityn (updated)
desloratadine, Rhinitis, Allergic, Perennial, Urticaria, Rhinitis, Allergic, Seasonal
Date of authorisation: 15/01/2001, Revision: 39, Authorised, Last updated: 24/02/2021 -
List item
Human medicine European public assessment report (EPAR): Hirobriz Breezhaler (updated)
indacaterol maleate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 30/11/2009, Revision: 17, Authorised, Last updated: 24/02/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Incurin (updated)
estriol, Dogs
Date of authorisation: 24/03/2000, Revision: 7, Authorised, Last updated: 24/02/2021 -
List item
Human medicine European public assessment report (EPAR): Zyprexa Velotab (updated)
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 03/02/2000, Revision: 30, Authorised, Last updated: 24/02/2021 -
List item
Human medicine European public assessment report (EPAR): Ebymect (updated)
dapagliflozin propanediol monohydrate, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 15/11/2015, Revision: 16, Authorised, Last updated: 24/02/2021 -
List item
Human medicine European public assessment report (EPAR): Prepandrix (updated)
A/Indonesia/05/2005 (H5N1) like strain used (PR8-IBCDC-RG2), Influenza, Human, Immunization, Disease Outbreaks
Date of authorisation: 14/05/2008,
, Revision: 13, Withdrawn, Last updated: 23/02/2021
-
List item
Human medicine European public assessment report (EPAR): Januvia (updated)
sitagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 20/03/2007, Revision: 28, Authorised, Last updated: 23/02/2021 -
List item
Human medicine European public assessment report (EPAR): Remsima (updated)
infliximab, Arthritis, Psoriatic, Spondylitis, Ankylosing, Colitis, Ulcerative, Psoriasis, Crohn Disease, Arthritis, Rheumatoid
Date of authorisation: 10/09/2013,, Revision: 22, Authorised, Last updated: 23/02/2021